Theseus Pharmaceuticals Statistics
Total Valuation
Vasta Platform has a market cap or net worth of $339.29 million. The enterprise value is $498.03 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vasta Platform has 80.21 million shares outstanding. The number of shares has decreased by -4.12% in one year.
| Current Share Class | 15.77M |
| Shares Outstanding | 80.21M |
| Shares Change (YoY) | -4.12% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 10.02% |
| Owned by Institutions (%) | 7.60% |
| Float | 7.73M |
Valuation Ratios
The trailing PE ratio is 3.88 and the forward PE ratio is 10.73. Vasta Platform's PEG ratio is 0.21.
| PE Ratio | 3.88 |
| Forward PE | 10.73 |
| PS Ratio | 1.05 |
| Forward PS | 0.23 |
| PB Ratio | 0.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.63 |
| P/OCF Ratio | 7.00 |
| PEG Ratio | 0.21 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.47, with an EV/FCF ratio of 11.20.
| EV / Earnings | 5.76 |
| EV / Sales | 1.59 |
| EV / EBITDA | 7.47 |
| EV / EBIT | 16.04 |
| EV / FCF | 11.20 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.19 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 3.07 |
| Debt / FCF | 4.87 |
| Interest Coverage | 0.83 |
Financial Efficiency
Return on equity (ROE) is 10.03% and return on invested capital (ROIC) is 1.81%.
| Return on Equity (ROE) | 10.03% |
| Return on Assets (ROA) | 1.47% |
| Return on Invested Capital (ROIC) | 1.81% |
| Return on Capital Employed (ROCE) | 2.86% |
| Revenue Per Employee | $173,377 |
| Profits Per Employee | $47,801 |
| Employee Count | 1,808 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 2.54 |
Taxes
| Income Tax | -33.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.79% in the last 52 weeks. The beta is -0.11, so Vasta Platform's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | +51.79% |
| 50-Day Moving Average | 4.18 |
| 200-Day Moving Average | 3.42 |
| Relative Strength Index (RSI) | 54.99 |
| Average Volume (20 Days) | 10,668 |
Short Selling Information
The latest short interest is 52,218, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 52,218 |
| Short Previous Month | 36,925 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.68% |
| Short Ratio (days to cover) | 3.98 |
Income Statement
In the last 12 months, Vasta Platform had revenue of $313.47 million and earned $86.42 million in profits. Earnings per share was $1.09.
| Revenue | 313.47M |
| Gross Profit | 188.64M |
| Operating Income | 31.05M |
| Pretax Income | -24.77M |
| Net Income | 86.42M |
| EBITDA | 66.68M |
| EBIT | 31.05M |
| Earnings Per Share (EPS) | $1.09 |
Full Income StatementBalance Sheet
The company has $57.85 million in cash and $216.59 million in debt, giving a net cash position of -$158.74 million or -$1.98 per share.
| Cash & Cash Equivalents | 57.85M |
| Total Debt | 216.59M |
| Net Cash | -158.74M |
| Net Cash Per Share | -$1.98 |
| Equity (Book Value) | 905.91M |
| Book Value Per Share | 11.26 |
| Working Capital | 42.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $48.48 million and capital expenditures -$4.29 million, giving a free cash flow of $44.46 million.
| Operating Cash Flow | 48.48M |
| Capital Expenditures | -4.29M |
| Free Cash Flow | 44.46M |
| FCF Per Share | $0.55 |
Full Cash Flow StatementMargins
Gross margin is 60.18%, with operating and profit margins of 9.90% and 27.57%.
| Gross Margin | 60.18% |
| Operating Margin | 9.90% |
| Pretax Margin | 16.94% |
| Profit Margin | 27.57% |
| EBITDA Margin | 21.27% |
| EBIT Margin | 9.90% |
| FCF Margin | 14.18% |
